These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 320223
1. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure. Pimstone B, Epstein S, Hamilton SM, LeRoith D, Hendricks S. J Clin Endocrinol Metab; 1977 Feb; 44(2):356-60. PubMed ID: 320223 [Abstract] [Full Text] [Related]
2. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. Sheppard M, Shapiro B, Pimstone B, Kronheim S, Berelowitz M, Gregory M. J Clin Endocrinol Metab; 1979 Jan; 48(1):50-3. PubMed ID: 422706 [Abstract] [Full Text] [Related]
3. Thyrotrophin response to intravenous thyrotrophin-releasing hormone in patients with hepatic and renal disease. Pokroy N, Epstein S, Hendricks S, Pimstone B. Horm Metab Res; 1974 Mar; 6(2):132-6. PubMed ID: 4208128 [No Abstract] [Full Text] [Related]
5. Metabolic clearance and plasma half-disappearance time of D-TRP6 and exogenous luteinizing hormone-releasing hormone. Barron JL, Millar RP, Searle D. J Clin Endocrinol Metab; 1982 Jun; 54(6):1169-73. PubMed ID: 6210706 [Abstract] [Full Text] [Related]
6. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men. Castro-Fernández C, Olivares A, Söderlund D, López-Alvarenga JC, Zambrano E, Veldhuis JD, Ulloa-Aguirre A, Méndez JP. J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115 [Abstract] [Full Text] [Related]
7. Evidence for attenuation of hypothalamic gonadotropin-releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. Veldhuis JD, Wilkowski MJ, Zwart AD, Urban RJ, Lizarralde G, Iranmanesh A, Bolton WK. J Clin Endocrinol Metab; 1993 Mar; 76(3):648-54. PubMed ID: 8445020 [Abstract] [Full Text] [Related]
8. Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure. Duntas L, Wolf CF, Keck FS, Rosenthal J. Clin Nephrol; 1992 Oct; 38(4):214-8. PubMed ID: 1424308 [Abstract] [Full Text] [Related]
9. Distribution volume, metabolic clearance and plasma half disappearance time of exogenous luteinizing hormone releasing hormone in normal women and women with obesity and anorexia nervosa. Chikamori K, Suehiro F, Ogawa T, Sato K, Mori H, Oshima I, Saito S. Acta Endocrinol (Copenh); 1981 Jan; 96(1):1-6. PubMed ID: 7006293 [Abstract] [Full Text] [Related]
10. Disappearance rates of plasma growth hormone after intravenous somatostatin in renal and liver disease. Pimstone BL, Le Roith D, Epstein S, Kronheim S. J Clin Endocrinol Metab; 1975 Aug; 41(2):392-3. PubMed ID: 1159052 [Abstract] [Full Text] [Related]
11. Renal clearance, metabolic clearance rate, and half-life of human growth hormone in young and aged subjects. Sohmiya M, Kato Y. J Clin Endocrinol Metab; 1992 Dec; 75(6):1487-90. PubMed ID: 1464653 [Abstract] [Full Text] [Related]
12. Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure. Kawai S, Ichikawa Y, Homma M. J Clin Endocrinol Metab; 1985 May; 60(5):848-54. PubMed ID: 3980669 [Abstract] [Full Text] [Related]
13. Response to rapid removal of intermediate molecular weight solutes in uremic man. Silverstein ME, Ford CA, Lysaght MJ, Henderson LW. Trans Am Soc Artif Intern Organs; 1974 May; 20 B():614-21. PubMed ID: 4450311 [No Abstract] [Full Text] [Related]
14. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. Haffner D, Schaefer F, Girard J, Ritz E, Mehls O. J Clin Invest; 1994 Mar; 93(3):1163-71. PubMed ID: 8132756 [Abstract] [Full Text] [Related]
15. Impaired elimination of meperidine in patients with liver disease. McHorse TS, Klotz U, Wilkinson G, Schenker S. Trans Assoc Am Physicians; 1974 Mar; 87():281-7. PubMed ID: 4456737 [No Abstract] [Full Text] [Related]
16. Turnover of thyrotropin-releasing hormone in patients with chronic renal failure and chronic alcoholic liver disease. Iversen E, Schmitz O, Laurberg P. Acta Endocrinol (Copenh); 1990 Aug; 123(2):179-84. PubMed ID: 2120878 [Abstract] [Full Text] [Related]
17. Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man. Nicholson WE, DeCherney GS, Jackson RV, DeBold CR, Uderman H, Alexander AN, Rivier J, Vale W, Orth DN. J Clin Endocrinol Metab; 1983 Dec; 57(6):1263-9. PubMed ID: 6313734 [Abstract] [Full Text] [Related]